BGMSP — Bio Green Med Solution, Inc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1130166 ·
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 778,000 | 143,000 | -246,000 | -197,000 | 7,564,000 | 3,339,000 | 804,000 |
| Dec 2025 | 666,000 | 121,000 | -1,082,000 | -611,000 | 8,185,000 | 3,505,000 | 1,343,000 |
| Sep 2025 | 81,000 | 17,000 | -992,000 | -988,000 | 8,158,000 | 3,838,000 | 1,062,000 |
| Jun 2025 | 0 | — | -1,317,000 | -1,318,000 | 4,401,000 | 4,275,000 | 770,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-4,770,000
Investing CF
$0
Financing CF
$5,264,000
CapEx
—
Dividends Paid
$-20,000
Buybacks
—
EPS Diluted TTM
—
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-454,411,000
Inventory
$1,384,000
Receivables
$1,257,000
ST Investments
—
EBIT TTM
$-8,427,000
Pretax Income TTM
$-2,991,000
Interest Exp TTM
—
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$1,525,000
EBITDA
$-4,454,250
Free Cash Flow
—
Enterprise Value
$3,211,276
Total Cash
$3,339,000
Total Debt
$0
Shares Out
—
Trailing EPS
—
Book Value
$1.24
ROE
20.6%
ROA
-49.3%
Div Yield
50.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 747,000 | -8,427,000 | — | 8,185,000 | 1,343,000 | — | -4,770,000 |
| Dec 2024 | 43,000 | -12,004,000 | — | 4,094,000 | 6,268,000 | — | -7,990,000 |
| Dec 2023 | 420,000 | -25,453,000 | — | 8,805,000 | 8,198,000 | — | -16,112,000 |
| Dec 2022 | 0 | -27,656,000 | — | 28,050,000 | 7,617,000 | — | -20,827,000 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| LLY | ELI LILLY & Co | $949.47B | $1064.74 | — |
| JNJ | JOHNSON & JOHNSON | $554.09B | $230.18 | — |
| ABBV | AbbVie Inc. | $376.54B | $213.12 | — |
| MRK | Merck & Co., Inc. | $295.69B | $119.72 | — |
| AZN | ASTRAZENECA PLC | $290.30B | $187.19 | — |
News headlines (Yahoo Finance, 1h cache)
BIO GREEN MED SOLUTION REPORTS FIRST QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
2026-05-14 20:15 · Yahoo
Aterian, Inc. Announces Definitive Agreement for the Sale of its Marquee Brand Portfolio for $18 Million Subject to Adjustments
2026-04-28 12:00 · Yahoo
BIO GREEN MED SOLUTION REPORTS FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
2026-03-30 20:15 · Yahoo
Bio Green Med Solution Reports Third Quarter Financial Results and Provides Business Update
2025-11-13 21:40 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.